GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Valiant Laboratories Ltd

Valiant Laboratories — QC Manager Bhanudas D. Patil resigns effective April 22, 2026

MANAGEMENT ▼ Concern Flagged MEDIUM RISK
📅 Filed on BSE: 23 Apr 2026, 03:05 PM IST  ·  BSE ID: 5d2852ed-520f-480d-9429-057fbda7d8a4
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's quality control manager quit on April 22, 2026, due to personal reasons. The company announced it to stock exchanges as required by law.
🤖 AI Summary
  • Mr. Bhanudas D. Patil, QC Manager, resigned effective April 22, 2026, citing personal commitments
  • Resignation disclosed under SEBI Regulation 30 — mandatory material event disclosure
  • No replacement or succession plan disclosed in filing
  • Company recently listed — incorporated 2021 per CIN L24299MH2021PLC365904
🔢 Key Numbers — exact figures from BSE filing, not rounded
Effective date of cessation
April 22, 2026
Filing disclosure date
April 23, 2026
🏢 How This Affects the Company
⚙️
Operational Impact
QC Manager role is now vacant. No interim arrangement or successor disclosed. Impact on quality assurance processes and capacity depends on backfill timeline and depth of replacement bench.
⚠️
Risk Impact
Departure of quality management personnel introduces operational continuity risk. Quality assurance function coverage and timeline for role refilling are undisclosed.
👥 What This Means For Shareholders
✅
Action Required
No immediate action required. Monitor next quarterly results and management commentary on QC function staffing.
👤
Who Is Affected
All shareholders. Operational continuity risk affects business execution, product quality delivery, and compliance readiness across all shareholders proportionally.
🔍
Management Signal
Abrupt departure without disclosed succession plan suggests either no advance contingency planning or delayed communication on backfill strategy.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q1 FY27 results for QC/quality assurance commentary and headcount disclosure
Next management update filing disclosing QC Manager replacement appointment or interim arrangement
Annual report for organization chart changes and quality control function restaffing status
MEDIUM RISK Quality control manager vacancy without disclosed succession plan creates operational continuity and compliance risk. Pharmaceutical/lab operations require consistent QC oversight.
💡 Investor Takeaway
Valiant Laboratories lost its QC Manager effective April 22, 2026. No replacement or interim arrangement disclosed. Quality assurance function coverage and timeline for restaffing remain unknown. Monitor Q1 FY27 results for operational impact.
⚖️ Strengths & Concerns

⚠️ Concerns

  • QC Manager departure creates immediate gap in quality control function with no succession plan disclosed
  • No interim arrangement, backfill timeline, or impact mitigation strategy communicated to stakeholders
You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.